Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Riboflavin-UVA Induced Collagen Crosslinking Treatment for Corneal Ectasia

NCT01123057 is registered in ClinicalTrials.gov with Singapore National Eye Centre as lead sponsor.

NCT NCT01123057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01123057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Riboflavin-UVA Induced Collagen Crosslinking Treatment for Corneal Ectasia
Lead sponsor
Singapore National Eye Centre
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2008
Completion date
June 30, 2010
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal ectasia